Yi Liu

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 5

Top Topics

Epithelial Mesenchymal Transition

Transforming Growth Factor

Top Venues

Science translational medicine

International journal of nanomedicine

This page only lists publications with an associated author ORCID identifier.

Publications

Haobo Bai, Qian Lu, Chunxiang Wu, Fang Xu, Jiayu Liu, Ke Wang, Hao Ding, Yibing Yin, Yi Liu, Xiaofei Lai, Ju Cao
Bone morphogenetic protein 9 is a candidate prognostic biomarker and host-directed therapy target for sepsis. Science translational medicine 16 (732) (2024)
Yi Liu, David Quintanar Guerrero, David Lechuga-Ballesteros, Mingdian Tan, Faiz Ahmad, Bilal Aleiwi, Edmund Lee Ellsworth, Bin Chen, Mei-Sze Chua, Samuel So
Lipid-Based Self-Microemulsion of Niclosamide Achieved Enhanced Oral Delivery and Anti-Tumor Efficacy in Orthotopic Patient-Derived Xenograft of Hepatocellular Carcinoma in Mice. International journal of nanomedicine 19 (2024)
Haobo Bai, Qian Lu, Chunxiang Wu, Fang Xu, Jiayu Liu, Ke Wang, Hao Ding, Yibing Yin, Yi Liu, Xiaofei Lai, Ju Cao
Bone morphogenetic protein 9 is a candidate prognostic biomarker and host-directed therapy target for sepsis. Science translational medicine 16 (732) (2024)
Yi Liu, David Quintanar Guerrero, David Lechuga-Ballesteros, Mingdian Tan, Faiz Ahmad, Bilal Aleiwi, Edmund Lee Ellsworth, Bin Chen, Mei-Sze Chua, Samuel So
Lipid-Based Self-Microemulsion of Niclosamide Achieved Enhanced Oral Delivery and Anti-Tumor Efficacy in Orthotopic Patient-Derived Xenograft of Hepatocellular Carcinoma in Mice. International journal of nanomedicine 19 (2024)
Haobo Bai, Qian Lu, Chunxiang Wu, Fang Xu, Jiayu Liu, Ke Wang, Hao Ding, Yibing Yin, Yi Liu, Xiaofei Lai, Ju Cao
Bone morphogenetic protein 9 is a candidate prognostic biomarker and host-directed therapy target for sepsis. Science translational medicine 16 (732) (2024)